Zenas BioPharma, Inc. (ZBIO)
21.74
+0.69
(+3.28%)
USD |
NASDAQ |
Apr 16, 16:00
21.74
0.00 (0.00%)
After-Hours: 20:00
Zenas BioPharma EPS Diluted (Quarterly) : -5.172 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 0.2025 |
| AnaptysBio, Inc. | 1.583 |
| Gilead Sciences, Inc. | 1.742 |
| Nkarta, Inc. | -0.3702 |
| Cullinan Therapeutics, Inc. | -0.8566 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -240.44M |
| Total Expenses (Quarterly) | 240.44M |
| Enterprise Value | 1.049B |
| Earnings Yield | -38.84% |
| Normalized Earnings Yield | -26.91 |